New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
November 26, 2014
13:25 EDTBMYAchillion to benefit from Bristol-Myers CRL, says FBR Capital
FBR Capital expects Achillion (ACHN) to benefit from the complete response letter that the FDA sent to Bristol-Myers (BMY) on its daclatasvir HCV drug. The firm thunks the letter increases the value of GT-3 HCV patients for Achillion. FBR says that GT-3 patients constitute 5% of HCV patients in the U.S. and significantly higher in Europe. It keeps an Outperform rating on Achillion.
11:38 EDTBMYBristol-Myers receives CRL from FDA for daclatasvir
Subscribe for More Information
11:36 EDTBMYBristol-Myers receives CRL from FDA for daclatasvir
Subscribe for More Information
10:21 EDTJNJJohnson & Johnson Zytiga lost share for second month, says Wells Fargo
Subscribe for More Information
09:35 EDTPBRActive equity options trading
Active equity options trading according to Track Data: AAPL HPQ SDRL TASR FB TXN NFLX AMZN TWTR PBR
06:00 EDTHESStocks with implied volatility movement; HES SD
Subscribe for More Information
November 25, 2014
10:00 EDTGRMNGarmin Outdoor demand soft, says Cleveland Research
Subscribe for More Information
10:00 EDTPBROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:39 EDTPBRActive equity options trading
Subscribe for More Information
06:59 EDTPBRPetrobras confirms receipt of subpoena from SEC
Subscribe for More Information
06:31 EDTPBRPetrobras upgraded to Buy from Neutral at Citigroup
Citigroup upgraded Petrobras to Buy citing the recent pullback in shares and expectations for earnings growth in 2015-2016. Citi believes the company's challenges are priced into shares at current levels. It lowered its price target for the stock to $13 from $17.
November 24, 2014
17:15 EDTVNOVornado to acquire 440,000 square foot mixed-use commercial property
Subscribe for More Information
13:32 EDTJCPJ.C. Penney director discloses 100K share purchase at $7.28
J.C. Penney director Javier Teruel disclosed in a filing late Friday the purchase of 100K shares at $7.28 on Nov. 19. Shares of JCP are up 5.5% in early afternoon trading.
11:33 EDTPBRStocks with call strike movement; PBR GDX
Subscribe for More Information
11:25 EDTJNJStryker, Smith & Nephew rise after reports of renewed bid
Subscribe for More Information
10:54 EDTGRMNOptions with increasing implied volatility: KLAC GRMN
Subscribe for More Information
10:14 EDTNKTRFDA grants QIDP designation to Bayer's Amikacin Inhale, Ciprofloxacin DPI
Subscribe for More Information
10:00 EDTHESOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aruba Networks (ARUN) upgraded to Outperform from Market Perform at Raymond James... Banco Bilbao (BBVA) upgraded to Neutral from Underperform at BofA/Merrill... Berry Plastics (BERY) upgraded to Outperform from Market Perform at BMO Capital... Denny's (DENN) upgraded to Buy from Neutral at Janney Capital... Hess Corp. (HES) upgraded to Outperform from Market Perform at Raymond James... Huaneng Power (HNP) upgraded to Buy from Neutral at BofA/Merrill... Infoblox (BLOX) upgraded to Buy from Hold at Needham... Kate Spade (KATE) upgraded at BofA/Merrill... Lumber Liquidators (LL) upgraded to Overweight from Equal Weight at Morgan Stanley... Occidental Petroleum (OXY) upgraded to Strong Buy from Outperform at Raymond James... PT Indosat (IIT) upgraded to Buy from Neutral at Nomura... Silvercorp Metals (SVM) upgraded to Outperform from Market Perform at Raymond James... Toro Company (TTC) upgraded to Buy from Neutral at Longbow... United Microelectronics (UMC) upgraded to Market Perform from Underperform at Bernstein.
09:39 EDTPBRActive equity options trading
Subscribe for More Information
09:26 EDTJNJFDA updates warning on laparoscopic power morcellators to treat uterine fibroids
The FDA announced it is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids. In an updated safety communication, originally issued in April, the FDA warns against using laparoscopic power morcellators in the removal of the uterus or fibroids in the vast majority of women. In an Immediately in Effect guidance, the FDA is also recommending that manufacturers of laparoscopic power morcellators include in their product labeling specific safety statements in the form of a boxed warning and two contraindications. Johnson & Johnson (JNJ), the largest manufacturer of morcellators, stopped selling the gynecological surgical tool in April and in August told customers to return any devices in their inventory. Intuitive Surgical's (ISRG) da Vinci surgical system can be used with tissue morcellators in such surgical procedures.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use